DLGAP5 has been reported as an underlying prognostic factor in lung cancer, BC, clear cell renal cell carcinoma, and colorectal cancer and the overexpression of DLGAP5 has been proved to be linked to poor prognosis in these cancers [15,16,17,18,19,20,21]. Here, DLGAP5 is linked to breast cancer.